Skip to main content

Flat Foot

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

MTI
MTIUT - Salt Lake City
1 program
Biodex balance systemN/A1 trial
Active Trials
NCT06606392Not Yet Recruiting60Est. Feb 2025
Paragon 28
Paragon 28CO - Englewood
1 program
Titan 3D Wedge SystemN/A1 trial
Active Trials
NCT03421665Withdrawn0Est. Sep 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MTIBiodex balance system
Paragon 28Titan 3D Wedge System

Clinical Trials (2)

Total enrollment: 60 patients across 2 trials

NCT06606392MTIBiodex balance system

Effect of Biodex Balance Training and Short Foot Exercise on Myoelectric Activity of Paraspinal Muscles in Subjects with Flexible Flatfoot

Start: Oct 2024Est. completion: Feb 202560 patients
N/ANot Yet Recruiting
NCT03421665Paragon 28Titan 3D Wedge System

Evaluation of the Titan 3-D™ Wedge System

Start: Jun 2018Est. completion: Sep 20220
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.